Drug Research

It's not your imagination: As infections from the fast mutating BA.5 coronavirus subvariant rise throughout the United States, more people are becoming infected with COVID-19 for the second or third time. However, on aggregate, these reinfections do not appear...

On the second attempt, Azurity Pharmaceuticals was able to secure an FDA nod for its zonisamide oral suspension, making it the first firm to do so in the United States. In February 2021, Massachusetts-based Azurity acquired the rights to the...

Imcivree, also known as setmelanotide, has been recommended by the National Institute for Health and Care Excellence (NICE) in its advice for managing obesity and hunger brought on by pro-opiomelanocortin (POMC) inadequacy, according to Rhythm Pharmaceuticals. Patients with a...

According to a paper examining the present environment for antimicrobial development in Brazil, India, and South Africa, lowering regulatory barriers to hasten the clearance of novel antibiotics will aid in the development and accessibility of those drugs. Given that antibiotics...

The FDA has given the go-ahead to the Serum Institute of India (SII) to eventually supply a COVID-19 vaccine to the U.S. with Novavax's Nuvaxovid. The emergency use authorization granted to Novavax's recombinant protein-based vaccination on July 13th means SII...

According to a recent study conducted by Tel Aviv University and Ben Gurion University of the Negev in conjunction with the Israeli Ministry of Health, the fourth COVID-19 vaccination is effective in preventing the Omicron form from infecting the...

The COVID-19 vaccine from Novavax Inc. may cause serious allergic reactions, according to the European Medicines Agency. The vaccine's product label in the United States forbids giving the shot to anyone who has had a history of acute toxicity to...